株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

注入型ドラッグデリバリーの世界市場予測 2021年:種類・治療・利用パターン・投与・流通チャネル・患者の治療環境別分析

Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Cancer), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), Distribution Channel (Hospital), Patient Care Setting (Hospital, Home Care) - Forecast to 2021

発行 MarketsandMarkets 商品コード 338418
出版日 ページ情報 英文 258 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.88円で換算しております。
Back to Top
注入型ドラッグデリバリーの世界市場予測 2021年:種類・治療・利用パターン・投与・流通チャネル・患者の治療環境別分析 Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Cancer), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), Distribution Channel (Hospital), Patient Care Setting (Hospital, Home Care) - Forecast to 2021
出版日: 2017年02月06日 ページ情報: 英文 258 Pages
概要

世界の注入型ドラッグデリバリー市場は2016年の3,623億8,000万米ドルから2021年までに6,245億米ドルに達すると予測され、2016年から2021年にかけては11.5%のCAGRで成長すると見込まれています。

当レポートでは、世界の注入型ドラッグデリバリー市場について分析し、市場の基本的構造や最新動向、主な市場促進・阻害要因、市場規模の動向見通し、種類・製剤容器・治療用途・利用パターン・投与部位・使用施設・地域別の詳細動向、市場競争の状態、今後の技術開発・市場発展の方向性、主要企業のプロファイルなどを調査・考察しております。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 注入型ドラッグデリバリー市場概要
  • 注入型ドラッグデリバリー市場:使用施設別
  • 注入型ドラッグデリバリー市場の地理的分析:投与部位別
  • 注入型ドラッグデリバリー市場:製剤容器別
  • 注入型ドラッグデリバリー市場の地理的スナップショット

第5章 市場概要

  • イントロダクション
  • 市場ダイナミクス
    • 促進要因
    • 抑制要因
    • 機会
    • 課題

第6章 規制シナリオ

  • イントロダクション
  • FDA(米国;食品医薬品局)およびCE(欧州評議会)の承認
  • 欧州医薬品庁(EMA)
  • 臨床試験

第7章 注入型ドラッグデリバリー市場:種類別

  • イントロダクション
  • デバイス
    • 従来型注入デバイス
      • マテリアル別
      • 製品別
      • ユーザビリティ別
    • 自己注射デバイス
      • 無針注射器
      • オートインジェクター
      • ペン型注射器
    • ウェアラブルインジェクター
    • その他のデバイス
  • 製剤
    • 従来型ドラッグデリバリー
      • ソリューション
      • 再構成/凍結乾燥製剤
      • 懸濁液 (サスペンション)
      • 乳濁液 (エマルション)
    • 新しいドラッグデリバリー製剤
      • コロイド分散
      • 微小粒子
    • 長時間作用型 (持続型) 注入製剤

第8章 注入型ドラッグデリバリー市場:製剤容器別

  • イントロダクション
  • アンプル
  • 小瓶
  • カートリッジ

第9章 注入型ドラッグデリバリー市場:治療用途別

  • イントロダクション
  • 自己免疫疾患
    • リウマチ性関節炎
    • 多発性硬化症
    • クローン病
    • 乾癬
    • その他の自己免疫疾患
  • ホルモン障害
    • 糖尿病
    • 貧血
    • リプロダクティブヘルス疾患
    • 抗血栓症/血栓溶解療法
    • 骨粗しょう症
    • 成長ホルモン欠損症 (GHD)
  • 希少疾患
  • がん
  • その他
    • 疼痛管理
    • アレルギー治療
    • 美容治療
    • C型肝炎
    • 血友病

第10章 注入型ドラッグデリバリー市場:利用パターン別

  • イントロダクション
  • 治療
  • 予防接種
  • その他

第11章 注入型ドラッグデリバリー市場:投与部位別

  • イントロダクション
  • 皮膚(皮内および皮下)
  • 循環/筋骨格(静脈内、心臓内、筋肉内、腹膜内)
  • 臓器(硝子体内および関節内)
  • 中枢神経系(大脳内およびクモ膜下)

第12章 注入型ドラッグデリバリー市場:流通チャネル別

  • イントロダクション
  • 病院
  • 小売薬局

第13章 注入型ドラッグデリバリー市場:使用施設別

  • イントロダクション
  • 病院・診療所
  • 在宅医療現場
  • その他

第14章 注入型ドラッグデリバリー市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア
  • その他 (ROW)

第15章 競合情勢

  • 概要
  • 市場シェア分析
  • 競合状況・動向

第16章 企業プロファイル

  • イントロダクション
  • BAXTER INTERNATIONAL, INC.
  • BECTON, DICKINSON AND COMPANY
  • GERRESHEIMER AG
  • PFIZER, INC.
  • SCHOTT AG
  • ELI LILLY AND COMPANY
  • SANDOZ(A DIVISION OF NOVARTIS AG)
  • テルモ
  • TEVA PHARMACEUTICAL INDUSTRIES LTD.

第17章 付録

図表リスト

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MD 3680

The global injectable drug delivery market, in terms of value, is projected to reach USD 624.50 billion by 2021 from USD 362.38 billion in 2016, at a CAGR of 11.5% during the forecast period.

The increase in the use of biologics, the increase in the prevalence of chronic diseases, the increasing occurrence of needlestick injuries, and the benefits of injections (convenience, ease of use, and reduced pain) have driven the growth of the injectable drug delivery market. These factors have increased the demand for devices such as safety syringes, prefilled syringes, and autoinjectors. However, the growing use of alternative delivery methods, safety concerns, and risk of transmission of blood-borne infections may hinder the growth of the market.

The injectable drug delivery is segmented based on type, formulation packaging, therapeutic application, usage pattern, site of administration, distribution channel, facility of use, and regions. Injectable drug delivery market by distribution channel is further segmented into hospitals and pharma stores. Hospitals are expected to account for a large share in this market, as hospitals provide injectables for the inpatients as well as to the outpatients, owing to which there is maximum sale of injectable formulations and devices through the hospitals. In addition, it provides pharmacy care for inpatients as well as patients from other clinics, ambulatory centers, patients discharged from healthcare facilities, and those receiving home care.

The Injectable drug delivery market by facility of use is segmented into hospitals and clinics, home care settings, and other facilities of use. The hospitals and clinics segment is expected to account for the largest share of the market, primarily due to the rising incidence of chronic diseases such as diabetes and cancer which require a large number of injectables for their treatment.

Asia is expected to be the fastest growing region in the market from 2016 to 2021 due to the rising incidence of chronic and autoimmune diseases, the rising aging population, and the high penetration of self-injection techniques & technologies in countries such as China, Japan, and India.

Prominent players in the injectable drug delivery market include Becton, Dickinson and Company (U.S.), Baxter International (U.S.), Pfizer (U.S.), Gerresheimer AG (Germany), Schott AG (Germany), Eli Lilly and Company (U.S.), and Terumo Corporation (Japan).

Research Coverage:

The report defines, describes, and forecasts the injectable drug delivery market on the basis of type, formulation packaging, therapeutic application, usage pattern, site of administration, distribution channel, and facility of use. It provides detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, challenges). The study tracks and analyzes competitive developments such as joint ventures, mergers & acquisitions, product developments, and expansions in the injectable drug delivery market across four main regions, namely, North America, Asia, Europe, and the Rest of the World (RoW).

Reasons to Buy the Report:

The report provides clients market size information on various segments of the injectable drug delivery market. This report also provides access to the quantitative data on the market. This report covers -

  • Current and forecast assessment of the injectable drug delivery market
  • Country-wise assessment of each of the segments
  • Global market share analysis for major segments of the injectable drug delivery market
  • Adoption Trends of injectable drug delivery for major geographic markets
  • Five-year coverage of strategic developments of top players in the injectable drug delivery market
  • Product Portfolio mapping of leading players in the injectable drug delivery market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.3. KEY DATA FROM SECONDARY SOURCES
  • 2.4. KEY DATA FROM PRIMARY SOURCES
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. INJECTABLE DRUG DELIVERY: MARKET OVERVIEW
  • 4.2. INJECTABLE DRUG DELIVERY MARKET, BY FACILITY OF USE
  • 4.3. GEOGRAPHIC ANALYSIS: INJECTABLE DRUG DELIVERY MARKET, BY SITE OF ADMINISTRATION
  • 4.4. INJECTABLE DRUG DELIVERY MARKET, BY FORMULATION PACKAGING
  • 4.5. GEOGRAPHICAL SNAPSHOT: INJECTABLE DRUG DELIVERY MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Rising prevalence of chronic diseases
      • 5.2.1.2. Increase in demand for self-injection devices
      • 5.2.1.3. Growth in the biologics market
      • 5.2.1.4. Technological advancements and new product launches
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Infections associated with needlestick injuries
      • 5.2.2.2. Product recalls
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Increase in demand for biosimilar and generic injectables
        • 5.2.3.1.1. Biosimilars
        • 5.2.3.1.2. Generic injectables
      • 5.2.3.2. Contraceptive injectables
    • 5.2.4. CHALLENGE
      • 5.2.4.1. Preference for other modes of drug delivery

6. REGULATORY SCENARIO

  • 6.1. INTRODUCTION
  • 6.2. FDA AND CE APPROVALS
  • 6.3. THE EUROPEAN MEDICINES AGENCY (EMA)
  • 6.4. CLINICAL TRIALS

7. INJECTABLE DRUG DELIVERY MARKET, BY TYPE

  • 7.1. INTRODUCTION
  • 7.2. DEVICES
    • 7.2.1. CONVENTIONAL INJECTION DEVICES
      • 7.2.1.1. By Material
        • 7.2.1.1.1. Glass
        • 7.2.1.1.2. Plastic
      • 7.2.1.2. By Product
        • 7.2.1.2.1. Fillable syringes
        • 7.2.1.2.2. Prefilled syringes
      • 7.2.1.3. By Usability
        • 7.2.1.3.1. Reusable injection devices
        • 7.2.1.3.2. Disposable injection devices
    • 7.2.2. SELF-INJECTION DEVICES
      • 7.2.2.1. Needle-free Injectors
        • 7.2.2.1.1. By product
        • 7.2.2.1.1.1. Fillable needle-free injectors
        • 7.2.2.1.1.2. Prefilled needle-free injectors
        • 7.2.2.1.2. By technology
        • 7.2.2.1.2.1. Jet-based needle-free injectors
        • 7.2.2.1.2.2. Spring-based needle-free injectors
        • 7.2.2.1.2.3. Laser-powered needle-free injectors
        • 7.2.2.1.2.4. Vibration-based needle-free injectors
        • 7.2.2.1.3. By usability
        • 7.2.2.1.3.1. Reusable needle-free injectors
        • 7.2.2.1.3.2. Disposable needle-free injectors
      • 7.2.2.2. Autoinjectors
        • 7.2.2.2.1. By Product
        • 7.2.2.2.1.1. Fillable autoinjectors
        • 7.2.2.2.1.2. Prefilled autoinjectors
        • 7.2.2.2.2. By Technology
        • 7.2.2.2.2.1. Automated autoinjectors
        • 7.2.2.2.2.2. Manual autoinjectors
        • 7.2.2.2.3. By Design
        • 7.2.2.2.3.1. Standardized autoinjectors
        • 7.2.2.2.3.2. Customized autoinjectors
        • 7.2.2.2.4. By Usability
        • 7.2.2.2.4.1. Reusable autoinjectors
        • 7.2.2.2.4.2. Disposable autoinjectors
      • 7.2.2.3. Pen injectors
        • 7.2.2.3.1. By Product
        • 7.2.2.3.1.1. Single-chambered pen injectors
        • 7.2.2.3.1.2. Dual-chambered pen injectors
        • 7.2.2.3.2. By Design
        • 7.2.2.3.2.1. Standard pen injectors
        • 7.2.2.3.2.2. Customized pen injectors
        • 7.2.2.3.3. By Usability
        • 7.2.2.3.3.1. Reusable pen injectors
        • 7.2.2.3.3.2. Disposable pen injectors
      • 7.2.2.4. Wearable injectors
      • 7.2.2.5. Other Devices
  • 7.3. FORMULATIONS
    • 7.3.1. CONVENTIONAL DRUG DELIVERY FORMULATIONS
      • 7.3.1.1. Solutions
      • 7.3.1.2. Reconstituted/lyophilized formulations
      • 7.3.1.3. Suspensions
      • 7.3.1.4. Emulsions
    • 7.3.2. NOVEL DRUG DELIVERY FORMULATIONS
      • 7.3.2.1. Colloidal dispersions
        • 7.3.2.1.1. Niosomes
        • 7.3.2.1.2. Liposomes
        • 7.3.2.1.3. Polymeric/mixed micelles
        • 7.3.2.1.4. Nanoparticles
        • 7.3.2.1.4.1. Solid-lipid nanoparticles
        • 7.3.2.1.4.2. Nanosuspensions
        • 7.3.2.1.4.3. Nanoemulsions
      • 7.3.2.2. Microparticles
        • 7.3.2.2.1. Microspheres
        • 7.3.2.2.2. Microcapsules
    • 7.3.3. LONG-ACTING INJECTION FORMULATIONS

8. INJECTABLE DRUG DELIVERY MARKET, BY FORMULATION PACKAGING

  • 8.1. INTRODUCTION
  • 8.2. AMPULES
  • 8.3. VIALS
  • 8.4. CARTRIDGES
  • 8.5. BOTTLES

9. INJECTABLE DRUG DELIVERY MARKET, BY THERAPEUTIC APPLICATION

  • 9.1. INTRODUCTION
  • 9.2. AUTOIMMUNE DISEASES
    • 9.2.1. RHEUMATOID ARTHRITIS
    • 9.2.2. MULTIPLE SCLEROSIS (MS)
    • 9.2.3. CROHN'S DISEASE
    • 9.2.4. PSORIASIS
    • 9.2.5. OTHER AUTOIMMUNE DISEASES
  • 9.3. HORMONAL DISORDERS
    • 9.3.1. DIABETES
    • 9.3.2. ANEMIA
    • 9.3.3. REPRODUCTIVE HEALTH DISEASE
    • 9.3.4. ANTITHROMBOTIC/THROMBOLYTIC THERAPY
    • 9.3.5. OSTEOPOROSIS
    • 9.3.6. GROWTH HORMONE DEFICIENCY (GHD)
  • 9.4. ORPHAN DISEASES
  • 9.5. CANCER
  • 9.6. OTHER THERAPEUTIC APPLICATIONS
    • 9.6.1. PAIN MANAGEMENT
    • 9.6.2. ALLERGIES
    • 9.6.3. AESTHETIC TREATMENT
    • 9.6.4. HEPATITIS C
    • 9.6.5. HEMOPHILIA

10. INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN

  • 10.1. INTRODUCTION
  • 10.2. CURATIVE CARE
  • 10.3. IMMUNIZATION
  • 10.4. OTHERS

11. INJECTABLE DRUG DELIVERY MARKET, BY SITE OF ADMINISTRATION

  • 11.1. INTRODUCTION
  • 11.2. SKIN (INTRADERMAL AND SUBCUTANEOUS)
  • 11.3. CIRCULATORY/MUSCULOSKELETAL SYSTEM (INTRAVENOUS, INTRACARDIAC, INTRAMUSCULAR, AND INTRAPERITONEAL)
  • 11.4. ORGANS (INTRAVITREAL AND INTRA-ARTICULAR)
  • 11.5. CENTRAL NERVOUS SYSTEM (INTRACEREBRAL AND INTRATHECAL)

12. INJECTABLE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL

  • 12.1. INTRODUCTION
  • 12.2. HOSPITALS
  • 12.3. RETAIL PHARMACY STORES

13. INJECTABLE DRUG DELIVERY MARKET, BY FACILITY OF USE

  • 13.1. INTRODUCTION
  • 13.2. HOSPITALS AND CLINICS
  • 13.3. HOME CARE SETTINGS
  • 13.4. OTHER FACILITIES OF USE

14. INJECTABLE DRUG DELIVERY MARKET, BY REGION

  • 14.1. INTRODUCTION
  • 14.2. NORTH AMERICA
    • 14.2.1. U.S.
    • 14.2.2. CANADA
  • 14.3. EUROPE
    • 14.3.1. GERMANY
    • 14.3.2. FRANCE
    • 14.3.3. U.K.
    • 14.3.4. ITALY
    • 14.3.5. SPAIN
    • 14.3.6. REST OF EUROPE (ROE)
  • 14.4. ASIA
    • 14.4.1. CHINA
    • 14.4.2. JAPAN
    • 14.4.3. INDIA
    • 14.4.4. REST OF ASIA
  • 14.5. REST OF THE WORLD (ROW)

15. COMPETITIVE LANDSCAPE

  • 15.1. OVERVIEW
  • 15.2. MARKET SHARE ANALYSIS
  • 15.3. COMPETITIVE SITUATION AND TRENDS
    • 15.3.1. PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
    • 15.3.2. PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS
    • 15.3.1. EXPANSIONS
    • 15.3.2. ACQUISITIONS

16. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 16.1. INTRODUCTION
  • 16.2. BAXTER INTERNATIONAL, INC.
  • 16.3. BECTON, DICKINSON AND COMPANY
  • 16.4. GERRESHEIMER AG
  • 16.5. PFIZER, INC.
  • 16.6. SCHOTT AG
  • 16.7. ELI LILLY AND COMPANY
  • 16.8. SANDOZ (A DIVISION OF NOVARTIS AG)
  • 16.9. TERUMO CORPORATION
  • 16.10. TEVA PHARMACEUTICAL INDUSTRIES LTD.

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

17. APPENDIX

  • 17.1. INSIGHTS FROM INDUSTRY EXPERTS
  • 17.2. DISCUSSION GUIDE
  • 17.3. OTHER RECENT DEVELOPMENTS
  • 17.4. AVAILABLE CUSTOMIZATIONS
  • 17.5. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 17.6. RT: REAL-TIME MARKET INTELLIGENCE
  • 17.7. RELATED REPORTS
  • 17.8. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: PRODUCT RECALLS (2013-2015)
  • TABLE 2: INJECTABLE DRUGS GOING OFF-PATENT IN THE U.S.
  • TABLE 3: LIST OF REGULATORY AUTHORITIES IN MAJOR COUNTRIES
  • TABLE 4: LIST OF FDA APPROVED IN THE MARKET (2015-2016)
  • TABLE 5: INJECTABLE DRUGS IN PHASE III CLINICAL TRIALS
  • TABLE 6: PRODUCT RECALLS (2015-2016)
  • TABLE 7: INJECTABLE DRUG DELIVERY MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 8: INJECTABLE DRUG DELIVERY DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 9: INJECTABLE DRUG DELIVERY DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 10: CONVENTIONAL INJECTION DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 11: CONVENTIONAL INJECTION DEVICES MARKET SIZE, BY MATERIAL, 2014-2021 (USD BILLION)
  • TABLE 12: CONVENTIONAL GLASS INJECTION DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 13: CONVENTIONAL PLASTIC INJECTION DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 14: CONVENTIONAL INJECTION DEVICES MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
  • TABLE 15: CONVENTIONAL FILLABLE INJECTION DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 16: CONVENTIONAL PREFILLED INJECTION DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 17: CONVENTIONAL INJECTION DEVICES MARKET SIZE, BY USABILITY, 2014-2021 (USD BILLION)
  • TABLE 18: CONVENTIONAL REUSABLE INJECTION DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 19: CONVENTIONAL DISPOSABLE INJECTION DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 20: SELF-INJECTION DEVICES MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 21: SELF-INJECTION DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 22: NEEDLE-FREE INJECTORS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 23: NEEDLE-FREE INJECTORS MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
  • TABLE 24: FILLABLE NEEDLE-FREE INJECTORS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 25: PREFILLED NEEDLE-FREE INJECTORS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 26: NEEDLE-FREE INJECTORS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD MILLION)
  • TABLE 27: LIST OF SOME OF THE NEEDLE-FREE JET INJECTORS AVAILABLE IN THE MARKET
  • TABLE 28: JET-BASED NEEDLE-FREE INJECTORS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 29: LIST OF SOME OF THE NEEDLE-FREE SPRING-BASED INJECTORS AVAILABLE IN THE MARKET
  • TABLE 30: SPRING-BASED NEEDLE-FREE INJECTORS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 31: LASER-POWERED NEEDLE-FREE INJECTORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 32: VIBRATION-BASED NEEDLE-FREE INJECTORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 33: NEEDLE-FREE INJECTORS MARKET SIZE, BY USABILITY, 2014-2021 (USD BILLION)
  • TABLE 34: REUSABLE NEEDLE-FREE INJECTORS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 35: DISPOSABLE NEEDLE-FREE INJECTORS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 36: AUTOINJECTORS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 37: AUTOINJECTORS MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
  • TABLE 38: FILLABLE AUTOINJECTORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 39: PREFILLED AUTOINJECTORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 40: AUTOINJECTORS MARKET SIZE, BY TECHNOLOGY, 2014-2021 (USD BILLION)
  • TABLE 41: AUTOMATED AUTOINJECTORS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 42: MANUAL AUTOINJECTORS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 43: AUTOINJECTORS MARKET SIZE, BY DESIGN, 2014-2021 (USD BILLION)
  • TABLE 44: STANDARDIZED AUTOINJECTORS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 45: CUSTOMIZED AUTOINJECTORS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 46: AUTOINJECTOR MARKET SIZE, BY USABILITY, 2014-2021 (USD BILLION)
  • TABLE 47: REUSABLE AUTOINJECTORS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 48: DISPOSABLE AUTOINJECTORS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 49: PEN INJECTORS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 50: COMMERCIALLY AVAILABLE PEN INJECTORS
  • TABLE 51: PEN INJECTORS MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
  • TABLE 52: SINGLE-CHAMBERED PEN INJECTORS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 53: COMMERCIALLY AVAILABLE DUAL-CHAMBERED PEN INJECTORS
  • TABLE 54: DUAL-CHAMBERED PEN INJECTORS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 55: PEN INJECTORS MARKET SIZE, BY DESIGN, 2014-2021 (USD BILLION)
  • TABLE 56: STANDARD PEN INJECTORS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 57: CUSTOMIZED PEN INJECTORS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 58: PEN INJECTORS MARKET SIZE, BY USABILITY, 2014-2021 (USD BILLION)
  • TABLE 59: REUSABLE PEN INJECTORS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 60: DISPOSABLE PEN INJECTORS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 61: WEARABLE INJECTORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 62: OTHER DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 63: INJECTABLE DRUG DELIVERY FORMULATIONS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 64: INJECTABLE DRUG DELIVERY FORMULATIONS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 65: CONVENTIONAL DRUG DELIVERY FORMULATIONS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 66: CONVENTIONAL DRUG DELIVERY FORMULATIONS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 67: SOLUTIONS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 68: RECONSTITUTED/LYOPHILIZED FORMULATIONS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 69: SUSPENSIONS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 70: EMULSIONS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 71: NOVEL DRUG DELIVERY FORMULATIONS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 72: NOVEL DRUG DELIVERY FORMULATIONS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 73: COLLOIDAL DISPERSIONS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 74: COLLOIDAL DISPERSIONS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 75: NIOSOMES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 76: LIPOSOMES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 77: POLYMERIC/MIXED MICELLES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 78: NANOPARTICLES MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 79: NANOPARTICLES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 80: SOLID-LIPID NANOPARTICLES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 81: NANOSUSPENSIONS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 82: NANOEMULSIONS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 83: MICROPARTICLES MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 84: MICROPARTICLES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 85: MICROSPHERES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 86: MICROCAPSULES MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 87: LONG-ACTING INJECTION FORMULATIONS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 88: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION PACKAGING, 2014-2021 (USD BILLION)
  • TABLE 89: INJECTABLE DRUG DELIVERY MARKET SIZE FOR FORMULATION PACKAGING, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 90: INJECTABLE DRUG DELIVERY MARKET SIZE FOR AMPULES, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 91: INJECTABLE DRUG DELIVERY MARKET SIZE FOR VIALS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 92: INJECTABLE DRUG DELIVERY MARKET SIZE FOR CARTRIDGES, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 93: INJECTABLE DRUG DELIVERY MARKET SIZE FOR BOTTLES, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 94: INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 95: INJECTABLE DRUG DELIVERY MARKET SIZE FOR AUTOIMMUNE DISEASES, BY INDICATION, 2014-2021 (USD BILLION)
  • TABLE 96: INJECTABLE DRUG DELIVERY MARKET SIZE FOR AUTOIMMUNE DISEASES, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 97: INJECTABLE DRUG DELIVERY MARKET SIZE FOR RHEUMATOID ARTHRITIS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 98: INJECTABLE DRUG DELIVERY MARKET SIZE FOR MULTIPLE SCLEROSIS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 99: INJECTABLE DRUG DELIVERY MARKET SIZE FOR CROHN'S DISEASE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 100: INJECTABLE DRUG DELIVERY MARKET SIZE FOR PSORIASIS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 101: INJECTABLE DRUG DELIVERY MARKET SIZE FOR OTHER AUTOIMMUNE DISEASES, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 102: INJECTABLE DRUG DELIVERY MARKET SIZE FOR HORMONAL DISORDERS, BY INDICATION, 2014-2021 (USD BILLION)
  • TABLE 103: INJECTABLE DRUG DELIVERY MARKET SIZE FOR HORMONAL DISORDERS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 104: INJECTABLE DRUG DELIVERY MARKET SIZE FOR DIABETES, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 105: INJECTABLE DRUG DELIVERY MARKET SIZE FOR ANEMIA, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 106: INJECTABLE DRUG DELIVERY MARKET SIZE FOR REPRODUCTIVE HEALTH DISEASE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 107: INJECTABLE DRUG DELIVERY MARKET SIZE FOR ANTITHROMBOTIC/THROMBOLYTIC THERAPY, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 108: INJECTABLE DRUG DELIVERY MARKET SIZE FOR OSTEOPOROSIS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 109: INJECTABLE DRUG DELIVERY MARKET SIZE FOR GROWTH HORMONE DEFICIENCY, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 110: INJECTABLE DRUG DELIVERY MARKET SIZE FOR ORPHAN DISEASES, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 111: INJECTABLE DRUG DELIVERY MARKET SIZE FOR CANCER, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 112: INJECTABLE DRUG DELIVERY MARKET SIZE FOR OTHER THERAPEUTIC APPLICATIONS, BY INDICATION, 2014-2021 (USD BILLION)
  • TABLE 113: INJECTABLE DRUG DELIVERY MARKET SIZE FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 114: INJECTABLE DRUG DELIVERY MARKET SIZE FOR PAIN MANAGEMENT, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 115: INJECTABLE DRUG DELIVERY MARKET SIZE FOR ALLERGIES, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 116: INJECTABLE DRUG DELIVERY MARKET SIZE FOR AESTHETIC TREATMENTS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 117: INJECTABLE DRUG DELIVERY MARKET SIZE FOR HEPATITIS C, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 118: INJECTABLE DRUG DELIVERY MARKET SIZE FOR HEMOPHILIA, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 119: INJECTABLE DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN, 2014-2021 (USD BILLION)
  • TABLE 120: PIPELINE CURATIVE CARE DRUGS (2016-2020)
  • TABLE 121: INJECTABLE DRUG DELIVERY MARKET SIZE FOR CURATIVE CARE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 122: INJECTABLE DRUG DELIVERY MARKET SIZE FOR IMMUNIZATION, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 123: INJECTABLE DRUG DELIVERY MARKET SIZE FOR OTHER USAGE PATTERNS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 124: INJECTABLE DRUG DELIVERY MARKET SIZE, BY SITE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 125: MARKET FOR INJECTABLE DRUG DELIVERY THROUGH SKIN, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 126: MARKET FOR INJECTABLE DRUG DELIVERY THROUGH CIRCULATORY/MUSCULOSKELETAL SYSTEM, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 127: MARKET FOR INJECTABLE DRUG DELIVERY THROUGH ORGANS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 128: MARKET FOR INJECTABLE DRUG DELIVERY THROUGH CENTRAL NERVOUS SYSTEM, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 129: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2014-2021 (USD BILLION)
  • TABLE 130: INJECTABLE DRUG DELIVERY MARKET SIZE FOR HOSPITALS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 131: INJECTABLE DRUG DELIVERY MARKET SIZE FOR RETAIL PHARMACY STORES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 132: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 133: INJECTABLE DRUG DELIVERY MARKET SIZE FOR HOSPITALS AND CLINICS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 134: INJECTABLE DRUG DELIVERY MARKET SIZE FOR HOME CARE SETTINGS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 135: INJECTABLE DRUG DELIVERY MARKET SIZE FOR OTHER FACILITIES OF USE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 136: INJECTABLE DRUG DELIVERY MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 137: NORTH AMERICA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 138: NORTH AMERICA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 139: NORTH AMERICA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE, 2014-2021 (USD BILLION)
  • TABLE 140: NORTH AMERICA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2014-2021 (USD BILLION)
  • TABLE 141: NORTH AMERICA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 142: NORTH AMERICA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN, 2014-2021 (USD BILLION)
  • TABLE 143: NORTH AMERICA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY SITE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 144: NORTH AMERICA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 145: NORTH AMERICA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION PACKAGING, 2014-2021 (USD BILLION)
  • TABLE 146: NORTH AMERICA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2014-2021 (USD BILLION)
  • TABLE 147: U.S.: INJECTABLE DRUG DELIVERY MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 148: U.S.: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE, 2014-2021 (USD BILLION)
  • TABLE 149: U.S.: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2014-2021 (USD BILLION)
  • TABLE 150: U.S.: INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 151: U.S.: INJECTABLE DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN, 2014-2021 (USD BILLION)
  • TABLE 152: U.S.: INJECTABLE DRUG DELIVERY MARKET SIZE, BY SITE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 153: U.S.: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 154: U.S.: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION PACKAGING, 2014-2021 (USD BILLION)
  • TABLE 155: U.S.: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2014-2021 (USD BILLION)
  • TABLE 156: LIST OF INJECTABLES LAUNCHED IN CANADA (2014-2015)
  • TABLE 157: CANADA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 158: CANADA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE, 2014-2021 (USD BILLION)
  • TABLE 159: CANADA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2014-2021 (USD BILLION)
  • TABLE 160: CANADA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 161: CANADA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN, 2014-2021 (USD BILLION)
  • TABLE 162: CANADA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY SITE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 163: CANADA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 164: CANADA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION PACKAGING, 2014-2021 (USD BILLION)
  • TABLE 165: CANADA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2014-2021 (USD BILLION)
  • TABLE 166: EUROPE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 167: EUROPE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 168: EUROPE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE, 2014-2021 (USD BILLION)
  • TABLE 169: EUROPE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2014-2021 (USD BILLION)
  • TABLE 170: EUROPE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 171: EUROPE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN, 2014-2021 (USD BILLION)
  • TABLE 172: EUROPE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY SITE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 173: EUROPE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 174: EUROPE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION PACKAGING, 2014-2021 (USD BILLION)
  • TABLE 175: EUROPE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2014-2021 (USD BILLION)
  • TABLE 176: GERMANY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 177: GERMANY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE, 2014-2021 (USD BILLION)
  • TABLE 178: GERMANY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2014-2021 (USD BILLION)
  • TABLE 179: GERMANY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 180: GERMANY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN, 2014-2021 (USD BILLION)
  • TABLE 181: GERMANY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY SITE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 182: GERMANY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 183: GERMANY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION PACKAGING, 2014-2021 (USD BILLION)
  • TABLE 184: GERMANY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2014-2021 (USD BILLION)
  • TABLE 185: FRANCE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 186: FRANCE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE, 2014-2021 (USD BILLION)
  • TABLE 187: FRANCE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2014-2021 (USD BILLION)
  • TABLE 188: FRANCE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 189: FRANCE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN, 2014-2021 (USD BILLION)
  • TABLE 190: FRANCE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY SITE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 191: FRANCE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 192: FRANCE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION PACKAGING, 2014-2021 (USD BILLION)
  • TABLE 193: FRANCE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2014-2021 (USD BILLION)
  • TABLE 194: U.K.: INJECTABLE DRUG DELIVERY MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 195: U.K.: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE, 2014-2021 (USD BILLION)
  • TABLE 196: U.K.: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2014-2021 (USD BILLION)
  • TABLE 197: U.K.: INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 198: U.K.: INJECTABLE DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN, 2014-2021 (USD BILLION)
  • TABLE 199: U.K.: INJECTABLE DRUG DELIVERY MARKET SIZE, BY SITE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 200: U.K.: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 201: U.K.: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION PACKAGING, 2014-2021 (USD BILLION)
  • TABLE 202: U.K.: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2014-2021 (USD BILLION)
  • TABLE 203: ITALY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 204: ITALY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE, 2014-2021 (USD MILLION)
  • TABLE 205: ITALY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2014-2021 (USD BILLION)
  • TABLE 206: ITALY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 207: ITALY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN, 2014-2021 (USD BILLION)
  • TABLE 208: ITALY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY SITE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 209: ITALY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 210: ITALY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION PACKAGING, 2014-2021 (USD BILLION)
  • TABLE 211: ITALY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2014-2021 (USD BILLION)
  • TABLE 212: SPAIN: INJECTABLE DRUG DELIVERY MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 213: SPAIN: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE, 2014-2021 (USD MILLION)
  • TABLE 214: SPAIN: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2014-2021 (USD BILLION)
  • TABLE 215: SPAIN: INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 216: SPAIN: INJECTABLE DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN, 2014-2021 (USD BILLION)
  • TABLE 217: SPAIN: INJECTABLE DRUG DELIVERY MARKET SIZE, BY SITE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 218: SPAIN: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 219: SPAIN: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION PACKAGING, 2014-2021 (USD BILLION)
  • TABLE 220: SPAIN: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2014-2021 (USD BILLION)
  • TABLE 221: ROE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 222: ROE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE, 2014-2021 (USD BILLION)
  • TABLE 223: ROE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2014-2021 (USD BILLION)
  • TABLE 224: ROE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 225: ROE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN, 2014-2021 (USD BILLION)
  • TABLE 226: ROE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY SITE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 227: ROE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 228: ROE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION PACKAGING, 2014-2021 (USD BILLION)
  • TABLE 229: ROE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2014-2021 (USD BILLION)
  • TABLE 230: ASIA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 231: ASIA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 232: ASIA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE, 2014-2021 (USD BILLION)
  • TABLE 233: ASIA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2014-2021 (USD BILLION)
  • TABLE 234: ASIA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 235: ASIA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN, 2014-2021 (USD BILLION)
  • TABLE 236: ASIA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY SITE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 237: ASIA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 238: ASIA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION PACKAGING, 2014-2021 (USD BILLION)
  • TABLE 239: ASIA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2014-2021 (USD BILLION)
  • TABLE 240: CHINA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 241: CHINA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE, 2014-2021 (USD BILLION)
  • TABLE 242: CHINA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2014-2021 (USD BILLION)
  • TABLE 243: CHINA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 244: CHINA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN, 2014-2021 (USD BILLION)
  • TABLE 245: CHINA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY SITE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 246: CHINA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 247: CHINA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION PACKAGING, 2014-2021 (USD BILLION)
  • TABLE 248: CHINA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2014-2021 (USD BILLION)
  • TABLE 249: JAPAN: INJECTABLE DRUG DELIVERY MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 250: JAPAN: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE, 2014-2021 (USD BILLION)
  • TABLE 251: JAPAN: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2014-2021 (USD BILLION)
  • TABLE 252: JAPAN: INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 253: JAPAN: INJECTABLE DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN, 2014-2021 (USD BILLION)
  • TABLE 254: JAPAN: INJECTABLE DRUG DELIVERY MARKET SIZE, BY SITE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 255: JAPAN: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 256: JAPAN: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION PACKAGING, 2014-2021 (USD BILLION)
  • TABLE 257: JAPAN: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2014-2021 (USD BILLION)
  • TABLE 258: INDIA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 259: INDIA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE, 2014-2021 (USD BILLION)
  • TABLE 260: INDIA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2014-2021 (USD BILLION)
  • TABLE 261: INDIA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 262: INDIA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN, 2014-2021 (USD BILLION)
  • TABLE 263: INDIA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY SITE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 264: INDIA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 265: INDIA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION PACKAGING, 2014-2021 (USD BILLION)
  • TABLE 266: INDIA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2014-2021 (USD BILLION)
  • TABLE 267: ROA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 268: ROA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE, 2014-2021 (USD MILLION)
  • TABLE 269: ROA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2014-2021 (USD BILLION)
  • TABLE 270: ROA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 271: ROA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN, 2014-2021 (USD MILLION)
  • TABLE 272: ROA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY SITE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 273: ROA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 274: ROA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION PACKAGING, 2014-2021 (USD BILLION)
  • TABLE 275: ROA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2014-2021 (USD BILLION)
  • TABLE 276: ROW: INJECTABLE DRUG DELIVERY MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 277: ROW: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE, 2014-2021 (USD BILLION)
  • TABLE 278: ROW: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2014-2021 (USD BILLION)
  • TABLE 279: ROW: INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 280: ROW: INJECTABLE DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN, 2014-2021 (USD BILLION)
  • TABLE 281: ROW: INJECTABLE DRUG DELIVERY MARKET SIZE, BY SITE OF ADMINISTRATION, 2014-2021 (USD BILLION)
  • TABLE 282: ROW: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION)
  • TABLE 283: ROW: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION PACKAGING, 2014-2021 (USD BILLION)
  • TABLE 284: ROW: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2014-2021 (USD BILLION)
  • TABLE 285: PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2013-2016)
  • TABLE 286: PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS (2013-2016)
  • TABLE 287: EXPANSIONS (2013-2016)
  • TABLE 288: ACQUISITIONS (2013-2016)

LIST OF FIGURES

  • FIGURE 1: INJECTABLE DRUG DELIVERY MARKET
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 4: MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • FIGURE 5: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY, DESIGNATION AND REGION
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: INJECTABLE DRUG DELIVERY MARKET SNAPSHOT, BY FORMULATION 2016 VS. 2021 (USD BILLION)
  • FIGURE 8: INJECTABLE DRUG DELIVERY MARKET, BY FACILITY OF USE 2016 VS. 2021 (USD BILLION)
  • FIGURE 9: INJECTABLE DRUG DELIVERY MARKET, BY THERAPEUTIC APPLICATION, 2016 VS 2021 (USD BILLION)
  • FIGURE 10: INJECTABLE DRUG DELIVERY MARKET, BY REGION (2016-2021)
  • FIGURE 11: INCREASING USE OF BIOLOGIC DRUGS AND RISING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET GROWTH
  • FIGURE 12: HOSPITALS AND CLINICS TO DOMINATE THE MARKET IN 2016
  • FIGURE 13: SKIN SEGMENT TO COMMAND THE LARGEST MARKET SHARE IN 2016
  • FIGURE 14: AMPULES TO DOMINATE THE INJECTABLE DRUG DELIVERY MARKET, IN 2016
  • FIGURE 15: CHINA TO REGISTER HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 16: INJECTABLE DRUG DELIVERY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 17: NORTH AMERICA: INJECTABLE DRUG DELIVERY MARKET SNAPSHOT
  • FIGURE 18: EUROPE: INJECTABLE DRUG DELIVERY MARKET SNAPSHOT
  • FIGURE 19: ASIA: INJECTABLE DRUG DELIVERY MARKET SNAPSHOT
  • FIGURE 20: REST OF THE WORLD: INJECTABLE DRUG DELIVERY MARKET SNAPSHOT
  • FIGURE 21: KEY PLAYERS ADOPTED INORGANIC GROWTH STRATEGIES BETWEEN 2013 AND 2016
  • FIGURE 22: INJECTABLE DRUG DELIVERY MARKET EVOLUTION FRAMEWORK, 2013-2016
  • FIGURE 23: GLOBAL INJECTABLE DRUG DELIVERY MARKET SHARE ANALYSIS, 2015
  • FIGURE 24: BATTLE FOR MARKET SHARE: PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS ARE THE KEY STRATEGIES ADOPTED BY MARKET PLAYERS
  • FIGURE 25: GEOGRAPHIC BENCHMARKING OF TOP 5 PLAYERS
  • FIGURE 26: BAXTER INTERNATIONAL, INC.: COMPANY SNAPSHOT (2015)
  • FIGURE 27: BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2015)
  • FIGURE 28: GERRESHEIMER AG: COMPANY SNAPSHOT (2015)
  • FIGURE 29: PFIZER, INC.: COMPANY SNAPSHOT (2015)
  • FIGURE 30: SCHOTT AG: COMPANY SNAPSHOT (2015)
  • FIGURE 31: ELI LILLY AND COMPANY: COMPANY SNAPSHOT (2015)
  • FIGURE 32: SANDOZ: COMPANY SNAPSHOT (2015)
  • FIGURE 33: TERUMO CORPORATION: COMPANY SNAPSHOT (2015)
  • FIGURE 34: TEVA PHARMACEUTICAL INDUSTRIES LTD.: COMPANY SNAPSHOT (2015)
Back to Top